News Search Results
Feb 18, 2025, 05:45 ET Lost Money on ICON Public Limited Company(ICLR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Feb 18, 2025, 03:30 ET LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
Feb. 18, 2025 /PRNewswire/ -- LoQus23 Therapeutics Ltd ("LoQus23"), a private biotechnology company investigating small molecule drugs that could stop the pathogenic triplet expansion that is the cause and driver of Huntington's
More news about: LoQus23 Therapeutics
Feb 18, 2025, 02:27 ET SBTi Verifies GenScript Biotech Corp's Carbon Emission Reduction Goals, Marking a Major Sustainability Milestone!
profoundly impacts humanity and the environment, requiring collective efforts from all sectors. GenScript has always adhered to its mission of 'using biotechnology to make humans and nature healthier.' With the recent successful verification of our carbon reduction targets by SBTi, we have established more
More news about: GenScript Biotech Corporation
Feb 17, 2025, 10:34 ET CanSinoBIO to Showcase China's Vaccine Innovation at 2025 World Government Summit in Dubai
innovative vaccine products targeting over ten infectious diseases. "CanSinoBIO is honored to stand as the exclusive representative of Chinese biotechnology companies at the conference," said Dr. Yu Xuefeng. "Our participation in this global platform underscores our dedication to advancing
More news about: CanSinoBIO
Feb 17, 2025, 10:18 ET CanSinoBIO to Showcase China's Vaccine Innovation at 2025 World Government Summit in Dubai
innovative vaccine products targeting over ten infectious diseases. "CanSinoBIO is honored to stand as the exclusive representative of Chinese biotechnology companies at the conference," said Dr. Yu Xuefeng. "Our participation in this global platform underscores our dedication to advancing
More news about: CanSinoBIO
Feb 16, 2025, 11:25 ET Amity University Rajasthan Successfully Concludes E-SUMMIT 2025: A Grand Celebration of Innovation and Entrepreneurship
2025. Amity University Rajastham, Jaipur provides students with cutting-edge laboratories for languages, media studies, education, pharmacy, biotechnology, engineering, hotel management, business management, and scientific research, as well as sophisticated facilities for a variety of research projects.
More news about: Amity University Rajasthan
Feb 15, 2025, 10:30 ET FAU Joins the Nation's Most Elite Research Universities and Colleges
student assistance in the discovery process. Looking toward the future, FAU is focused on expanding its graduate programs in key areas such as biotechnology, AI, cybersecurity and marine sciences. The university is committed to fostering interdisciplinary collaboration, ensuring that students and faculty
More news about: Florida Atlantic University
Feb 15, 2025, 10:00 ET ICLR INVESTOR NOTICE: ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
insufficient to shield ICON from the adverse effects of a significant market downturn; (iii) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Robbins Geller Rudman & Dowd LLP
Feb 14, 2025, 17:15 ET Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
intent to cure the deficiency during the second compliance period. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Feb 14, 2025, 16:01 ET AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Feb 14, 2025, 16:00 ET ICLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
were insufficient to shield ICON from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Bronstein, Gewirtz & Grossman, LLC
Feb 14, 2025, 14:34 ET Dignify Therapeutics Highlights Clinical Development Plans at BIO CEO & Investor Conference
PARK, N.C., Feb. 14, 2025 /PRNewswire/ -- Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological conditions, presented its clinical development
More news about: Dignify Therapeutics
Feb 14, 2025, 10:15 ET Microcarriers Market to Hit USD 3.05 Billion by 2029 with 8.0% CAGR | MarketsandMarkets™
microcarriers market is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organizations & contract manufacturing organizations, and cell banks. The pharmaceutical & biotechnology companies segment accounted for the largest share of the
More news about: MarketsandMarkets
Feb 14, 2025, 08:56 ET Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases
BOSTON, Feb. 14, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, today announced the successful completion of its oversubscribed
More news about: Bambusa Therapeutics
Feb 14, 2025, 08:30 ET European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
SAN DIEGO, Feb. 14, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today announced that the European Commission has granted
More news about: CSL
Feb 14, 2025, 08:27 ET Anivive Announces Completion of LAVERDIA®-CA1 Pivotal Field Study for Canine Lymphoma
globe. About Anivive Lifesciences Anivive Lifesciences is a software-driven pet pharmaceutical company at the forefront of biotechnology, artificial intelligence, and veterinary medicine. Our mission is to transform veterinary healthcare by accelerating the development of novel, affordable
More news about: Anivive Lifesciences Inc.
Feb 14, 2025, 08:25 ET ICLR Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against ICON Public Limited Company (ICLR) - Contact Kessler Topaz Meltzer & Check, LLP
insufficient to shield the company from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Kessler Topaz Meltzer & Check, LLP
Feb 14, 2025, 07:00 ET Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar,
More news about: Anixa Biosciences, Inc.
Feb 14, 2025, 05:45 ET Contact Levi & Korsinsky by April 11, 2025 Deadline to Join Class Action Against ICON Public Limited Company(ICLR)
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Feb 13, 2025, 23:30 ET Biologics Conference 2025 Concludes Successfully, Setting New Benchmarks in Biopharmaceutical Innovation and Collaboration
event commenced with an inaugural ceremony graced by Chief Guest Dr. Rajesh Gokhale, Secretary, Department of Biotechnology, Government of India. He was joined by Prof. A. B. Pandit, Vice Chancellor- ICT Mumbai, Program Chairs Dr.
More news about: Mumbai Biocluster
Feb 13, 2025, 23:30 ET Biologics Conference 2025 Concludes Successfully, Setting New Benchmarks in Biopharmaceutical Innovation and Collaboration
event commenced with an inaugural ceremony graced by Chief Guest Dr. Rajesh Gokhale, Secretary, Department of Biotechnology, Government of India. He was joined by Prof. A. B. Pandit, Vice Chancellor- ICT Mumbai, Program Chairs Dr.
More news about: Mumbai Biocluster
Feb 13, 2025, 20:31 ET BioVaxys Announces Application for Management Cease Trade Order
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the late filing of the need for additional capital to fund clinical trials, its lack of operating history,
More news about: BioVaxys Technology Corp.
Feb 13, 2025, 16:20 ET Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025
Feb. 13, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Thursday, February 27, 2025,
More news about: Heron Therapeutics, Inc.
Feb 13, 2025, 10:50 ET Web Content Management Market Size Worth $33.32 Billion, Globally, by 2031 Growing at 19.4% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 13, 2025, 10:30 ET Data Protection as a Service Market Size Worth $161.5 Billion, Globally, by 2031 Growing at 30.3% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners